Clinical Trial Update: Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM) [Phase 2]

View source ↗

Summary

Phase 2 trial comparing PPD10558 with atorvastatin in statin-intolerant patients due to statin-associated myalgia, focusing on safety and tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Hyperlipidemia
• Myalgia

Drugs mentioned

• PPD10558
• atorvastatin (atorvastatin)

Snippet

Sponsor: Furiex Pharmaceuticals, Inc | Conditions: Myalgia, Hypercholesterolemia | Phase 2 | Status: COMPLETED